Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUN13837 Injection for acute spinal cord injury
2012-004373-80Phase 2Completed
- Sponsor
- Asubio Pharma
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in spinal cord injury (SCI) and acute cervical spinal cord injury (ACSCI) comparing SUN13837 injection with Placebo (2 arms). Primary endpoint: Total SCIM III score at Day 112. Started Mar 2013; status: completed.
02
Drugs
sun13837
03
Conditions
spinal cord injury (SCI)acute cervical spinal cord injury (ACSCI)
Beyond the preview
Go deeper on 2012-004373-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004373-80.